Trusted Supply of Critical & Orphan Medicines, Worldwide!

Drug: Lifitegrast
Brand: Xiidra 5%
Manufacturer /
TM Owner
Bausch & Lomb Incorporated
Origin: USA

Xiidra 5% Eye Drops

Xiidra is an ophthalmology medicine containing Lifitegrast. It acts on the underlying disease process to relieve symptoms and improve clinical outcomes. It is used in the treatment of eye diseases. It is supplied as an eye drops (5%). It supports better disease control and quality of life when used as directed.
Strength: 5%
Pack Size: 60s
Storage: 20°C to 25°C
Form: Eye Drops

+91 900 500 9556

Global Shipping : Reliable Global Distribution Network

Express Delivery : Priority Shipping for Every Order

Secure Payments : Trusted Payment Protection System

Disclaimer
All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the 'Manufacturer/ TM Owner' section in compliance with statutory requirements. Read More

Secure Handling

24/7 Worldwide Support

Global Access

Worldwide Access to Health

Cold-Chain Expert

Excellence in Cold-Chain

Trusted Supply

Certified Medical Supply

Indications & Clinical Uses

  • Xiidra 5% (lifitegrast ophthalmic solution) is a prescription eye drop for the treatment of the signs and symptoms of dry eye disease in adults; safety and efficacy have not been established in patients under 17 years.
  • It is approved in the United States and is not authorised in the EU, because Novartis Europharm withdrew its EU application on 18 June 2020 after the European Medicines Agency judged the benefits did not outweigh the risks.
  • The US label holder is now Bausch & Lomb (the product was previously held by Novartis).
  • The dose is one drop in each eye twice daily, about 12 hours apart, from a single-use container supplied in foil pouches.
  • It is used by the patient at home after instruction from a healthcare provider, and contact lenses must be removed before use.

Side Effects

  • The most common side effects, occurring in 5% to 25% of patients, are instillation-site irritation (stinging or burning when the drop goes in), dysgeusia (an unusual or bitter taste) and decreased visual acuity (reduced or blurred vision).
  • Reactions in 1% to 5% of patients include blurred vision, red eyes (conjunctival hyperaemia), eye irritation, headache, watering eyes, eye discharge, eye discomfort, eye itching and sinusitis.
  • Rare serious reactions reported after approval include anaphylaxis, bronchospasm, difficulty breathing, throat swelling and angioedema (swelling of the face, lips or tongue); seek emergency help if these occur.
  • The label carries no boxed warning.
  • If the drop causes blurred vision, wait until your vision clears before driving.

Precautions & Warnings

  • Xiidra must not be used by anyone allergic to lifitegrast or any ingredient.
  • Remove contact lenses before putting in the drops and wait 15 minutes before reinserting them.
  • Use one single-use container for both eyes, then throw it away; do not reuse it or keep it for later.
  • Remove the container from its foil pouch only immediately before use, and keep unused containers in the original foil pouch at 20°C to 25°C.
  • There are no data on use in pregnant women; rabbit studies showed increased omphalocele at the lowest doses tested, although body exposure from eye drops is minimal, so discuss pregnancy with your provider.
  • Safety and efficacy in people under 17 years have not been established.
  • Tell your provider if your eyes become painful, very red or your vision worsens.

Avoid Interactions

  • The US prescribing information does not describe any drug interactions with Xiidra, and no medicines are listed that increase its effect or reduce its effectiveness.
  • Because contact lenses can interfere with the drops, remove them before dosing and reinsert them 15 minutes afterwards.
  • If you use other eye drops, tell your healthcare provider or pharmacist so they can advise on the order and spacing of use; do not mix drops in the same container.
  • Tell your provider about all prescription and non-prescription medicines and supplements you take, including any other eye treatments.

References

Frequently Asked Questions

Xiidra (lifitegrast) eye drops treat the signs and symptoms of dry eye disease in adults. Safety and effectiveness have not been established in people under 17. It is approved in the United States but is not authorised in the EU.

Simple Working Process

We have simplified the online drug ordering process into 4 easy steps to ensure
a safe, secure, and hassle-free experience for our customers.

Order Online

Place your order online and upload prescription in minutes with ease.

Order Confirmation

We verify your prescription and confirm your order quickly and securely.

Prescription Review

Reviewed by licensed pharmacists. Carefully processed and validated.

R

Receive Medicines

Approved order delivered fast, easy, and right to your doorstep or nearby Airport.

Global Standards. Trusted Care.

Trusted & Reliable – Your Partner in Global Distribution.

We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.